Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""natalizumab"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 7090
Tytuł:
Long-term effects of natalizumab on MRI activity and clinical outcomes in Japanese patients with relapsing-remitting multiple sclerosis.
Autorzy:
Saida T; Kansai Multiple Sclerosis Centre, Irino Clinic Inc, TCA Building 4F, 2-3-19 Motomachi, Naniwa-ku, Osaka-shi, Osaka, Japan. .; Kansai Multiple Sclerosis Centre, Kyoto Neurology Clinic, Ukyo-ku, Uzumasa-Yurigamoto-cho 8-32, Kyoto, 616-8144, Japan. .
Hao Q; Kansai Multiple Sclerosis Centre, Irino Clinic Inc, TCA Building 4F, 2-3-19 Motomachi, Naniwa-ku, Osaka-shi, Osaka, Japan.
Kanda M; Biogen Japan Ltd, Nihonbashi 1-chome Mitsui Building 14F 1-4-1, Nihonbashi, Chuo-ku, Tokyo, Japan.
Tani Y; Biogen Japan Ltd, Nihonbashi 1-chome Mitsui Building 14F 1-4-1, Nihonbashi, Chuo-ku, Tokyo, Japan.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2023 Aug 29; Vol. 23 (1), pp. 311. Date of Electronic Publication: 2023 Aug 29.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Natalizumab*/therapeutic use
Female ; Humans ; Male ; East Asian People ; Magnetic Resonance Imaging ; Retrospective Studies ; Adult ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Targeting Vascular Impairment, Neuroinflammation, and Oxidative Stress Dynamics with Whole-Body Cryotherapy in Multiple Sclerosis Treatment.
Autorzy:
Dziedzic, Angela (AUTHOR)
Maciak, Karina (AUTHOR)
Miller, Elżbieta Dorota (AUTHOR)
Starosta, Michał (AUTHOR)
Saluk, Joanna (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p3858. 18p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Response to Fingolimod in Multiple Sclerosis Patients Is Associated with a Differential Transcriptomic Regulation.
Autorzy:
Sánchez-Sanz, Alicia (AUTHOR)
Muñoz-Viana, Rafael (AUTHOR)
Sabín-Muñoz, Julia (AUTHOR)
Moreno-Torres, Irene (AUTHOR)
Brea-Álvarez, Beatriz (AUTHOR)
Rodríguez-De la Fuente, Ofir (AUTHOR)
García-Merino, Antonio (AUTHOR)
Sánchez-López, Antonio J. (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 3, p1372. 15p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Performance Measures and Plasma Biomarker Levels in Patients with Multiple Sclerosis after 14 Days of Fampridine Treatment: An Explorative Study.
Autorzy:
Thorning, Maria (AUTHOR)
Lambertsen, Kate Lykke (AUTHOR)
Jensen, Henrik Boye (AUTHOR)
Frich, Lars Henrik (AUTHOR)
Madsen, Jonna Skov (AUTHOR)
Olsen, Dorte Aalund (AUTHOR)
Holsgaard-Larsen, Anders (AUTHOR)
Nielsen, Helle Hvilsted (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 3, p1592. 13p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
Autorzy:
Lereim RR; Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.; Computational Biology Unit (CBU), Department of Informatics, University of Bergen, Bergen, Norway.
Nytrova P; Department of Neurology and Center for Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Guldbrandsen A; Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.; Computational Biology Unit (CBU), Department of Informatics, University of Bergen, Bergen, Norway.
Havrdova EK; Department of Neurology and Center for Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Myhr KM; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Barsnes H; Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.; Computational Biology Unit (CBU), Department of Informatics, University of Bergen, Bergen, Norway.
Berven FS; Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 25; Vol. 19 (3), pp. e0300914. Date of Electronic Publication: 2024 Mar 25 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/cerebrospinal fluid
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/cerebrospinal fluid
Humans ; Natalizumab/therapeutic use ; Proteome ; Anti-Inflammatory Agents/therapeutic use ; Biomarkers/metabolism ; Immunologic Factors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Use of Nitrosative Stress Molecules as Potential Diagnostic Biomarkers in Multiple Sclerosis.
Autorzy:
Räuber, Saskia (AUTHOR)
Förster, Moritz (AUTHOR)
Schüller, Julia (AUTHOR)
Willison, Alice (AUTHOR)
Golombeck, Kristin S. (AUTHOR)
Schroeter, Christina B. (AUTHOR)
Oeztuerk, Menekse (AUTHOR)
Jansen, Robin (AUTHOR)
Huntemann, Niklas (AUTHOR)
Nelke, Christopher (AUTHOR)
Korsen, Melanie (AUTHOR)
Fischer, Katinka (AUTHOR)
Kerkhoff, Ruth (AUTHOR)
Leven, Yana (AUTHOR)
Kirschner, Patricia (AUTHOR)
Kölsche, Tristan (AUTHOR)
Nikolov, Petyo (AUTHOR)
Mehsin, Mohammed (AUTHOR)
Marae, Gelenar (AUTHOR)
Kokott, Alma (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 2, p787. 12p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells.
Autorzy:
Tanasescu, Radu (AUTHOR)
Frakich, Nanci (AUTHOR)
Chou, I.-Jun (AUTHOR)
Filippini, Perla (AUTHOR)
Podda, Giulio (AUTHOR)
Xin, Gao (AUTHOR)
Muraleedharan, Ranjithmenon (AUTHOR)
Jerca, Oltita (AUTHOR)
Onion, David (AUTHOR)
Constantinescu, Cris S. (AUTHOR)
Pokaż więcej
Źródło:
Neurology & Therapy. Dec2023, Vol. 12 Issue 6, p2041-2052. 12p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Benefits of a mosaic approach for assessing cortical atrophy in individual multiple sclerosis patients.
Autorzy:
Tahedl, Marlene (AUTHOR)
Wiltgen, Tun (AUTHOR)
Voon, Cui Ci (AUTHOR)
Berthele, Achim (AUTHOR)
Kirschke, Jan S. (AUTHOR)
Hemmer, Bernhard (AUTHOR)
Mühlau, Mark (AUTHOR)
Zimmer, Claus (AUTHOR)
Wiestler, Benedikt (AUTHOR)
Pokaż więcej
Źródło:
Brain & Behavior. Dec2023, Vol. 13 Issue 12, p1-16. 16p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Varicella Zoster Associated Vasculopathy and Retinitis with Natalizumab Use in Multiple Sclerosis.
Autorzy:
Thayer EL; The Warren Alpert Medical School of Brown University; Rhode Island Hospital Department of Diagnostic Imaging, Providence, RI.
Rizvi SA; The Warren Alpert Medical School of Brown University; Rhode Island Hospital Department of Neurology, Providence, RI.
Tung GA; The Warren Alpert Medical School of Brown University; Rhode Island Hospital Department of Diagnostic Imaging, Providence, RI.
Pokaż więcej
Źródło:
Rhode Island medical journal (2013) [R I Med J (2013)] 2024 Jan 04; Vol. 107 (1), pp. 26-28. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Multiple Sclerosis*
Retinal Necrosis Syndrome, Acute*/complications
Chickenpox*/complications
Retinitis*
Herpes Zoster*
Female ; Humans ; Middle Aged ; Natalizumab/adverse effects ; Antibodies, Monoclonal, Humanized
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Natalizumab Treatment for Relapsing Multiple Sclerosis Stabilises Normal-Appearing White Matter Microstructure: A One-Year Prospective Ultra-High-Field Quantitative Imaging Study.
Autorzy:
Tanasescu, Radu (AUTHOR)
Mougin, Olivier (AUTHOR)
Chou, I-Jun (AUTHOR)
Al-Radaideh, Ali (AUTHOR)
Jerca, Oltita P. (AUTHOR)
Lim, Su-Yin (AUTHOR)
Gowland, Penny (AUTHOR)
Constantinescu, Cris S. (AUTHOR)
Pokaż więcej
Źródło:
Brain Sciences (2076-3425). Oct2023, Vol. 13 Issue 10, p1464. 11p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genetic Variant HLA-DRB1*0403 and Therapeutic Response to Disease-Modifying Therapies in Multiple Sclerosis: A Case-Control Study.
Autorzy:
Gomez-Gaitan, Esteban Alejandro (AUTHOR)
Garcia-Ortega, Yessica Eleanet (AUTHOR)
Saldaña-Cruz, Ana Miriam (AUTHOR)
Contreras-Haro, Betsabe (AUTHOR)
Gamez-Nava, Jorge Ivan (AUTHOR)
Perez-Guerrero, Emilio Edsaul (AUTHOR)
Nava-Valdivia, Cesar Arturo (AUTHOR)
Gallardo-Moya, Sergio (AUTHOR)
Martinez-Hernandez, Alejandra (AUTHOR)
Gonzalez Lopez, Laura (AUTHOR)
Rios-Gonzalez, Blanca Esthela (AUTHOR)
Marquez-Pedroza, Jazmin (AUTHOR)
Mendez-del Villar, Miriam (AUTHOR)
Esparza-Guerrero, Yussef (AUTHOR)
Villagomez-Vega, Alejandra (AUTHOR)
Macias Islas, Miguel Angel (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Oct2023, Vol. 24 Issue 19, p14594. 9p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Changes in the Expression of TGF-Beta Regulatory Pathway Genes Induced by Vitamin D in Patients with Relapsing-Remitting Multiple Sclerosis.
Autorzy:
Lozano-Ros, Alberto (AUTHOR)
Martínez-Ginés, María L. (AUTHOR)
García-Domínguez, José M. (AUTHOR)
Salvador-Martín, Sara (AUTHOR)
Goicochea-Briceño, Haydee (AUTHOR)
Cuello, Juan P. (AUTHOR)
Meldaña-Rivera, Ariana (AUTHOR)
Higueras-Hernández, Yolanda (AUTHOR)
Sanjurjo-Sáez, María (AUTHOR)
Álvarez-Sala-Walther, Luis A. (AUTHOR)
López-Fernández, Luis A. (AUTHOR)
Pokaż więcej
Źródło:
International Journal of Molecular Sciences. Oct2023, Vol. 24 Issue 19, p14447. 16p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Prevalence of Cancer in Patients with Multiple Sclerosis (MS) who were Under Treatment with Natalizumab (Tysabri): A Systematic Review and Meta-Analysis.
Autorzy:
Nasirzadeh, Amirreza
Jahanshahi, Reza
Ghajarzadeh, Mahsa
Mohammadi, Aida
Sahraian, Mohammad Ali
Moghadasi, Abdorreza Naser
Pokaż więcej
Źródło:
International Journal of Preventive Medicine. Sep2023, Vol. 14 Issue 1, p1-5. 5p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Concomitant diagnosis of multiple sclerosis and human immunodeficiency virus (HIV) infection: case report and the review of literature.
Autorzy:
Trinchillo A; Department of Neurosciences, Reproductive Sciences and Odontostomatology, 'Federico II' University, Naples, Italy. .
Spiezia AL; Department of Neurosciences, Reproductive Sciences and Odontostomatology, 'Federico II' University, Naples, Italy.
Carotenuto A; Department of Neurosciences, Reproductive Sciences and Odontostomatology, 'Federico II' University, Naples, Italy.
Tedeschi E; Department of Advanced Biomedical Sciences, 'Federico II' University, Naples, Italy.
Servillo G; Department of Neurosciences, Reproductive Sciences and Odontostomatology, 'Federico II' University, Naples, Italy.
Iacovazzo C; Department of Neurosciences, Reproductive Sciences and Odontostomatology, 'Federico II' University, Naples, Italy.
Borrelli F; Infectious Diseases Unit, 'Federico II' University, Naples, Italy.
Di Filippo G; Infectious Diseases Unit, 'Federico II' University, Naples, Italy.
Morra VB; Department of Neurosciences, Reproductive Sciences and Odontostomatology, 'Federico II' University, Naples, Italy.
Lanzillo R; Department of Neurosciences, Reproductive Sciences and Odontostomatology, 'Federico II' University, Naples, Italy.
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2023 Jul; Vol. 44 (7), pp. 2305-2309. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Multiple Sclerosis*/diagnosis
Multiple Sclerosis*/diagnostic imaging
HIV Infections*/complications
HIV Infections*/drug therapy
Leukoencephalopathy, Progressive Multifocal*/diagnosis
Leukoencephalopathy, Progressive Multifocal*/diagnostic imaging
Humans ; Natalizumab/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; HIV ; Immunologic Factors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis.
Autorzy:
Boz C; Department of Neurology, Karadeniz Technical University Medical Faculty, 61080, Trabzon, Turkey. .
Ozakbas S; Department of Neurology, Dokuz Eylul University, Izmir, Turkey.
Terzi M; Department of Neurology, Ondokuz Mayis University, Samsun, Turkey.
Karabudak R; Department of Neurology, Hacettepe University, Ankara, Turkey.
Sevim S; Department of Neurology, Mersin University, Mersin, Turkey.
Turkoglu R; Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
Soysal A; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey.
Balcı BP; Department of Neurology, Haseki Educational and Research Center, Istanbul, Turkey.
Efendi H; Department of Neurology, Kocaeli University, Izmit, Turkey.
Turan ÖF; Department of Neurology, Uludag University, Bursa, Turkey.
Yüceyar N; Department of Neurology, Ege University, Izmir, Turkey.
Yetkin MF; Department of Neurology, Erciyes University, Kayseri, Turkey.
Karahan SZ; Department of Neurology, Karadeniz Technical University Medical Faculty, 61080, Trabzon, Turkey.
Demirkıran M; Department of Neurology, Cukurova University, Adana, Turkey.
Guler S; Department of Neurology, Trakya University, Edirne, Turkey.
Agan K; Department of Neurology, Marmara University, Istanbul, Turkey.
Kıylıoğlu N; Department of Neurology, Aydın Adnan Menderes University, Aydin, Turkey.
Baba C; Department of Neurology, Dokuz Eylul University, Izmir, Turkey.
Tuncer A; Department of Neurology, Hacettepe University, Ankara, Turkey.
Köseoğlu M; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey.
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2023 Jun; Vol. 44 (6), pp. 2121-2129. Date of Electronic Publication: 2023 Jan 23.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis*/drug therapy
Humans ; Fingolimod Hydrochloride/therapeutic use ; Natalizumab/therapeutic use ; Treatment Outcome ; Recurrence ; Immunosuppressive Agents/therapeutic use ; Immunologic Factors/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical and economic evaluations of natalizumab, rituximab, and ocrelizumab for the management of relapsing-remitting multiple sclerosis in Saudi Arabia.
Autorzy:
Alharbi MA; Department of Pharmacy, King Saud Medical City, Riyadh, 12746, Saudi Arabia.
Aldosari F; Department of Pharmacy, King Saud Medical City, Riyadh, 12746, Saudi Arabia.
Althobaiti AH; Department of Neurology, King Saud Medical City, Riyadh, 12746, Saudi Arabia.
Abdullah FM; Department of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, Makkah, 24382, Saudi Arabia.
Aljarallah S; Department of Medicine, Neurology Division, College of Medicine, King Saud University, P.O. Box 3145, Riyadh, 12372, Saudi Arabia.
Alkhawajah NM; Department of Medicine, Neurology Division, College of Medicine, King Saud University, P.O. Box 3145, Riyadh, 12372, Saudi Arabia.
Alanazi M; Department of Pharmacy, King Khalid University Hospital, P.O. Box 3145, Riyadh, 12372, Saudi Arabia.
AlRuthia Y; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2454, Riyadh, 11451, Saudi Arabia. .; Pharmacoeconomics Research Unit, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2454, Riyadh, 11451, Saudi Arabia. .
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 May 26; Vol. 23 (1), pp. 552. Date of Electronic Publication: 2023 May 26.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis*/drug therapy
Female ; Humans ; Natalizumab/therapeutic use ; Rituximab/therapeutic use ; Immunologic Factors/therapeutic use ; Retrospective Studies ; Cost-Benefit Analysis ; Saudi Arabia ; Disease Progression
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4 T cell arrest on the inflamed BBB under flow in vitro.
Autorzy:
Soldati S; Theodor Kocher Institute, University of Bern, Freiestrasse 1, 3012, Bern, Switzerland.
Bär A; Theodor Kocher Institute, University of Bern, Freiestrasse 1, 3012, Bern, Switzerland.
Vladymyrov M; Theodor Kocher Institute, University of Bern, Freiestrasse 1, 3012, Bern, Switzerland.
Glavin D; Department of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
McGrath JL; Department of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
Gosselet F; Blood-Brain Barrier Laboratory, University of Artois, Lens, France.
Nishihara H; Theodor Kocher Institute, University of Bern, Freiestrasse 1, 3012, Bern, Switzerland.; Department of Neurotherapeutics, Yamaguchi University, Yamaguchi, Japan.
Goelz S; Biogen, Cambridge, MA, USA.
Engelhardt B; Theodor Kocher Institute, University of Bern, Freiestrasse 1, 3012, Bern, Switzerland. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2023 May 23; Vol. 20 (1), pp. 123. Date of Electronic Publication: 2023 May 23.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes*
Blood-Brain Barrier*
Humans ; Natalizumab ; Intercellular Adhesion Molecule-1 ; Integrin alpha4 ; CD4-Positive T-Lymphocytes
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients.
Autorzy:
Vaivade, Aina (AUTHOR)
Wiberg, Anna (AUTHOR)
Khoonsari, Payam Emami (AUTHOR)
Carlsson, Henrik (AUTHOR)
Herman, Stephanie (AUTHOR)
Al-Grety, Asma (AUTHOR)
Freyhult, Eva (AUTHOR)
Olsson-Strömberg, Ulla (AUTHOR)
Burman, Joachim (AUTHOR)
Kultima, Kim (AUTHOR)
Pokaż więcej
Źródło:
Lipids in Health & Disease. 7/7/2023, Vol. 22 Issue 1, p1-15. 15p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 7090

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies